GB8500263D0 - 4'-deoxy-4'-halodoxorubicin-14-esters - Google Patents

4'-deoxy-4'-halodoxorubicin-14-esters

Info

Publication number
GB8500263D0
GB8500263D0 GB858500263A GB8500263A GB8500263D0 GB 8500263 D0 GB8500263 D0 GB 8500263D0 GB 858500263 A GB858500263 A GB 858500263A GB 8500263 A GB8500263 A GB 8500263A GB 8500263 D0 GB8500263 D0 GB 8500263D0
Authority
GB
United Kingdom
Prior art keywords
halodoxorubicin
deoxy
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB858500263A
Other versions
GB2169286A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Priority to GB08500263A priority Critical patent/GB2169286A/en
Publication of GB8500263D0 publication Critical patent/GB8500263D0/en
Publication of GB2169286A publication Critical patent/GB2169286A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08500263A 1985-01-05 1985-01-05 4'-Deoxy-4'-halodoxorubicin-14-esters Withdrawn GB2169286A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08500263A GB2169286A (en) 1985-01-05 1985-01-05 4'-Deoxy-4'-halodoxorubicin-14-esters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08500263A GB2169286A (en) 1985-01-05 1985-01-05 4'-Deoxy-4'-halodoxorubicin-14-esters

Publications (2)

Publication Number Publication Date
GB8500263D0 true GB8500263D0 (en) 1985-02-13
GB2169286A GB2169286A (en) 1986-07-09

Family

ID=10572457

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08500263A Withdrawn GB2169286A (en) 1985-01-05 1985-01-05 4'-Deoxy-4'-halodoxorubicin-14-esters

Country Status (1)

Country Link
GB (1) GB2169286A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218087B (en) * 1988-04-22 1991-01-30 Erba Carlo Spa 4-demethoxy-4'-deoxy-4'iodo anthracycline glycosides
GB0114654D0 (en) * 2001-06-15 2001-08-08 Pharmacia & Upjohn Spa Anti-tumor compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL145536B (en) * 1968-04-12 1975-04-15 Farmaceutici Italia METHOD OF PREPARING A NEW ANTIBIOTIC OR ITS AGLYCON.
GB1368680A (en) * 1972-12-09 1974-10-02 Farmaceutici Italia Adriamycin derivatives
GB1499026A (en) * 1975-06-20 1978-01-25 Farmaceutici Italia Adriamycin esters
NL170737C (en) * 1975-11-12 1982-12-16 Rhone Poulenc Ind PROCESS FOR PREPARING ESTERS OF ADRIAMYCIN AGAINST TUMORS, AND PREPARING MEDICINES WITH ANTI-TUMOR ACTIVITY.
GB1511680A (en) * 1975-11-18 1978-05-24 Farmaceutici Italia Daunosaminyl anthracyclinones
DK160616C (en) * 1979-02-03 1991-09-02 Zaidan Hojin Biseibutsu PROCEDURE FOR PREPARING ANTHRACYCLINE DERIVATIVES OR ACID ADDITIONAL SALTS THEREOF
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides

Also Published As

Publication number Publication date
GB2169286A (en) 1986-07-09

Similar Documents

Publication Publication Date Title
GB2209202B (en) "heater"
GB8615141D0 (en) 5 6-epoxy-7-oxabicycloheptane
GB8615140D0 (en) 5 6-epoxy-7-oxabicycloheptane
CS843186A2 (en) Zpusob vyroby karbapenemovych derivatu nesoucich v poloze 2 kvarternizovany heterothioalkylthiosubstituent
PH22526A (en) 2-2' bi-ih-imidazoles
GB8521293D0 (en) 2 2 6 6-eteramethylpiperidylamides
CS715586A2 (en) Zpusob vyroby novych 2 substituovanych derivatu ergolinu
GB8500263D0 (en) 4'-deoxy-4'-halodoxorubicin-14-esters
CS440685A1 (en) Zpusob vyroby 2 merkaptoethansulfonove kyseliny
GB8612109D0 (en) 2 4-dichloro-5-nitrothiazole
GB8501210D0 (en) N-phosphoryl-/n-thio-phosphoryl-n'-s-triazinyl-formamidines
GB8531745D0 (en) 10beta-alkynyl-4-9(11)-estradiene derivatives
CS562185A1 (en) Zpusob pripravy chlorovanych 2 chlormetansulfonylaminodifenyleteru
GB8500261D0 (en) 4'-epidoxorubicin-14-esters
GB8500262D0 (en) 4'-deoxydoxorubicin-14-esters
CS131085A1 (en) Zpusob pripravy 3 fluorthiofenolu
CS840385A1 (en) Sposob vyroby modifikovaneho 2 merkaptobenztiazolu
CS49985A1 (en) Sposob pripravy vodnych roztokov 3 metakryloxypropylsilanolov
CS756285A2 (en) Zpusob vyroby substituovanych 4 benzylpiperazinylderivatu
CS604185A1 (en) Sposob vyroby 2 alkoxypropenov
CS240685A1 (en) 020485
CS230585A1 (en) Zpusob pripravy technickeho 4 sulfoftaliminu amonneho
CS13885A1 (en) 070185
CS131185A1 (en) Zpusob pripravy 3 fluornitrobenzenu
CS815785A2 (en) Zpusob vyroby 3 substituovanych 2 oxindolu

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)